Alzheimer's disease in Down syndrome and intellectual disability: A review

Irish Journal of Psychology

Volumn 27, Issue 3-4, 2006, Pages 114-129

  McGuire, Brian E ^a   Whyte, Niamh ^b   Hardardottir, Drifa ^b  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b Galway Association   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34250378331     PISSN: 03033910     EISSN: None     Source Type: Journal    
DOI: 10.1080/03033910.2006.10446235     Document Type: Review

References (96)

1. Albert, M. & Cohen, C. (1992). The Test for Severe Impairment: An instrument for the assessment of patients with severe cognitive dysfunction. Journal of the American Geriatric Society, 40, 449-453.
2. Alexander, G.E., Chen, K., Pietrini, P., Rapoport, S.I. & Reiman, E.M. (2002). Longitudinal PET evaluation of cerebral metabolic decline in dementia: A potential measure in Alzheimer's Disease treatment studies. American Journal of Psychiatry, 159, 738-745.
3. Almeida, O.P. (2002). Commentary on Knopman et al. Evidence-Based Mental Health, 5, 26.
4. rd ed.). Washington, DC: Author.
5. th ed.). Washington, DC: Author.
6. Aylward, E.H., Burt, D.B., Thorpe, L.U., Lai, F. & Dalton, A. (1997). Diagnosis of dementia in individuals with intellectual disability. Journal of Intellectual Disability Research, 41, 152-164.
7. Ball, S.L., Holland, A.J., Huppert, F.A., Treppner, P., Watson, P. & Hon, J. (2004). The modified CAMDEX informant interview is a valid and reliable tool for use in the diagnosis of dementia in adults with Down's syndrome. Journal of Intellectual Disability Research, 48, 611-620.
8. Barcikowska, M., Silverman, W., Zigman, W., Kozlowski, P.B., Kulawa, M., Rudelli, R. et al. (1989). Alzheimer-type neuropathology and clinical symptoms of dementia in mentally retarded people without Down Syndrome. American Journal of Mental Retardation, 93, 551-557.
9. Basten, C.J. & McGuire, B.E. (2000). Delirium: The role of the psychologist in assessment and treatment. Australian Psychologist, 35, 201-207.
10. Beery, K. & Buktenica, N. (1997). Developmental Test of Visual Motor Integration: Administration, scoring and teaching manual. Parsippany, NJ: Modern Curriculum Press.
11. Birks, J. (2006). Cholinesterase inhibitors for Alzheimer's disease. The Cochrane Library of Systematic Reviews, Issue 1.
12. Bruininks, R.M., Woodcock, R., Weatherman, R. & Hill, B. (1996). Scales of Independent Behavior - Revised. Chicago, IL: Riverside.
13. Burt, D.B. & Aylward, E.H. (1998). Asessment methods for the diagnosis of dementia. In M.P. Janicki & A.J. Dalton (Eds). Dementia, aging and intellectual disabilities: A handbook, (p 144-156). Philadelpha, PA: Brunner Mazel.
14. Burt, D.B. & Aylward, E.H. (1998). Test battery for the diagnosis of dementia in individuals with intellectual disability. Journal of Intellectual Disability Research, 44, 75-180.
15. Bush, A. & Beau, N. (2004). Risk factors for dementia in people with Down Syndrome: Issues in assessment and diagnosis. American Journal on Mental Retardation, 109, 83-97.
16. Cole, G., Neal, J.W., Fraser. W.I. & Cowie, V.A. (1994). Autopsy findings in patients with mental handicap. Journal of Intellectual Disability Research, 38, 9-26.
17. Cosgrave, M.P., Tyrrell, J., McCarron, M., Gill, M. & Lawlor, B.A. (2000). A five year followup study of dementia in persons with Down's syndrome: Early symptoms and patterns of deterioration. Irish Journal of Psychological Medicine, 17, 5-11.
18. Crayton, L., Oliver, C, Holland, A., Hall, S. & Bradbury, J. (1998). The neuropsychological assessment of age related cognitive deficits in adults with Down's Syndrome. Journal of Applied Research in Intellectual Disabilities, 11, 255-272.
19. Dalton, A.J., Fedor, B.L., Patti, P.J., Tsiouris, J.A. & Mehta, P.D. (2002). The Multidimensional Observation Scale for Elderly Subjects (MOSES): Studies in adults with intellectual disability. Journal of Intellectual and Developmental Disability, 27, 310-324.
20. Devenny, D.A., Krinsky-McHale, S.J., Sersen, G. & Silverman, W.P. (2000). Sequence of cognitive decline in dementia in adults with Down Syndrome. Journal of Intellectual Disability Research, 44, 654-665.
21. Doody, R.S., Stevens, J.C., Beck, C., Dubinsky, K.M., Kaye, J.A., Gwyther, L. et al. (2001). Practice parameter: Management of dementia (an evidence-based review). Neurology, 56, 1131-1132.
22. Duff, K., McCaffrey, R.J. & Solomon, G.S. (2002). The Pocket Smell Test: Successfully discriminating probable Alzheimer's dementia from vascular dementia and major depression. Journal of Neuropsychiatry and Clinical Neurosciences, 14, 197-201.
23. nd Ed. London: NFER-Nelson Publishing Co.
24. Evenhuis, H.M., Kengen, M.M.F. & Eurlings, H.A.L. (1990). Dementia Questionnaire for Mentally Retarded Persons. Zwammerdam, Netherlands: Hooge Burch Institute.
25. Forette, F., Seux, M.L., Staessen, J.A., Thijs, L., Birkenhager, W.H., Babarskiene, M.R. et al. (2002). The prevention of dementia with antihypertensive treatment: New data from the Systolic Hypertension in Europe (SystEur) study. Archives of Internal Medicine, 163, 197-198.
26. Gedye, A. (1995). Manual for the Dementia Scale for Down Syndrome. Vancouver, BC: Gedye Research and Consulting.
27. Granholm, A.C., Ford, K.A., Hyde, L.A., Bimonte, H.A., Hunter, C.L., Nelson, M. et al. (2002). Estrogen restores cognition and cholinergic phenotype in an animal model of Down Syndrome. Physiology & Behavior, 77, 371-385.
28. Gray, A.J., Staples, V., Murren, K., Dhariwal, A. & Bentham, P. (2001). Olfactory identification is impaired in clinic-based patients with vascular dementia and senile dementia of Alzheimer type. International Journal of Geriatric Psychiatry, 16, 513-517.
29. Hanson, R.H., Nord, G.B. & Wieseler, N.A. (1997). Length of life: A ten year retrospective study of 209 clients who died in Minnesota's state facilities for persons with developmental disabilities in the 1980s. Journal of Developmental and Physical Disabilities, 9, 39-46.
30. Heininger, K. (2000). A unifying hypothesis of Alzheimer's disease. III. Risk factors. Human Psychopharmacology: Clinical and Experimental, 15, 1-70.
31. Holland, A.J., Hon, J., Huppert, F.A. & Stevens, F. (2000). Incidence and course of dementia in people with Down's syndrome: Findings from a population-based study. Journal of Intellectual Disability Research, 44, 138-146.
32. Hollins, S., Attard, M.T., von Fraunhofer, N., McGuigan, S. & Sedgwick, P. (1998). Mortality in people with learning disability: Risks, causes and death certificate findings in London. Developmental Medicine and Child Neurology, 40, 50-56.
33. Huppert, F.A. (1994). Memory function in dementia and normal aging - Dimension or dichotomy? In F.A. Huppert, C. Brayne & D.W. O'Connor (Eds.), Dementia and normal aging (pp. 291-330). Cambridge: Cambridge University Press.
34. Janicki, M.P., Dalton, A.J., Henderson, C.M. & Davidson, P.W. (1999). Mortality and morbidity among older adults with intellectual disability: Health service considerations. Disability and Rehabilitation, 21, 284-294.
35. Janicki, M.P., Heller, T., Seltzer, G.B. & Hogg, J. (1996). Practice guidelines for the clinical assessment and care management of Alzheimer's Disease and other dementias among adults with intellectual disability. Journal of Intellectual Disability Research, 40, 374-382.
36. Jokinen, N. (2005). The content of available practice literature in dementia and intellectual disability. Dementia, 4, 327-339.
37. Kalsy, S. (2002, June). Down Syndrome and dementia: Issues in assessment. Paper presented at the Joint PSI/BPS Learning Disability Conference, Maynooth, Co. Kildare, Ireland.
38. Kalsy, S., McQuillan, S., Oliver, C. & Hall, S. (2002). The Assessment of Adults with Developmental Disabilities (AADS) questionnaire. The University of Birmingham & Birmingham Specialist Community NHS Trust.
39. Kaplan, E., Goodglass, H. & Weubtraub, S. (1978). The Boston Naming Test. Boston: E. Kaplan and H. Goodglass.
40. Kivipelto, M., Helkala, EX., Laakso, M.P., Hanninen, T., Hallikainen, M., Aihainen, K. et al. (2001). Midlife vascular risk factors and Alzheimer's disease in later life: Longitudinal, population-based study. British Medical Journal, 32, 1447-1451.
41. Knopman, D.S., DeKosky, S.F., Cummings, J.L., Chiu, H., Corey-Bloom, J., Relkin, N. et al. (2001). Practice parameter: Diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 56, 1143-1153.
42. Lavin, K.E., McGuire, B.E. & Hogan, M.J. (2006). Age at death of people with an intellectual disability in Ireland. Journal of Intellectual Disabilities, 10, 155-164.
43. Lawlor, B.A., McCarron, M., Wilson, G. & McLoughlin, M. (2001). Temporal lobeoriented CT scanning and dementia in Down's syndrome. International Journal of Geriatric Psychiatry, 16, 427-429.
44. Liddell, M.B., Lovestone, S. & Owen, M.J. (2001). Genetic risk of Alzheimer's disease: Advising relatives. British Journal of Psychiatry, 178, 7-11.
45. Lye, T.C. & Shores, E.A. (2000). Traumatic brain injury as a risk factor for Alzheimer's Disease: A review. Neuropsychology Review, 10, 115129.
46. McCarron, M., Gill, M., Lawlor, B. & Begley, C. (2002). Time spent caregiving for persons with the dual disability of Down's syndrome and Alzheimer's Disease. Journal of Intellectual Disabilities, 6, 263-279.
47. McCarthy, D. (1972). Manual for the McCarthy Scales of Children's Abilities. San Antonio, TX: The Psychological Corporation.
48. McGuire, B.E., Basten, C.J., Ryan, C.J. & Gallagher, J. (2000). 'Intensive Care Unit Syndrome': A dangerous misnomer. Archives of Internal Medicine, 160, 906-909.
49. McKeown, D.A., Doty, R.L., Perl, D.P., Frye, R.E., Simms, I. & Mester, A. (1996). Olfactory function in young adolescents with Down's syndrome. Journal of Neurology, Neurosurgery & Psychiatry, 61, 412-414.
50. Moss, M.B., Albert, M.S., Butters, N. & Payne, M. (1986). Differential patterns of memory loss among patients with Alzheimer's disease, Huntington's disease, and alcoholic Korsakoff s syndrome. Archives of Neurology, 43, 239-246.
51. Moss, S.C., Prosser, H., Costello, H., Simpson, N., Patel, P., Rowe, S. et al. (1998). Reliability and validity of the PAS-ADD Checklist for detecting psychiatric disorders in adults with intellectual disability. Journal of Intellectual Disability Research, 40, 457-465.
52. Nihira, K., Leland, H. & Lambert, N. (1993). AAMR Adaptive Behavior Scales Residential and Community Edition. Washington, DC: American Association on Mental Retardation.
53. Nijjar, R.K. & Murphy, C. (2002). Olfactory impairment increases as a function of age in persons with Down syndrome. Neurobiology of Aging, 23, 65-73.
54. Oliver, C., Crayton, L., Holland, A. & Hall, S. (2000). Cognitive deterioration in adults with Down Syndrome: Effects on the individual,
55. caregivers, and service use. American Journal on Mental Retardation, 105, 455-465.
56. Palmer, K., Backman, L., Winblad, B. & Fratiglioni, L. (2003). Detection of Alzheimer's disease and dementia in the preclinical phase: Population-based cohort study. British Medical Journal, 326, 245-250.
57. Patja, K., livanainen, M., Vesala, H., Oksanen, H. & Ruopilla, I. (2000). Life expectancy of people with intellectual disability: A 35-year follow-up study. Journal of Intellectual Disability Research, 44, 591-599.
58. Petrella, J.R., Coleman, R.E. & Doraiswamy, P.M. (2003). Neuroimaging and early diagnosis of Alzheimer's Disease: A look to the future. Radiology, 226, 315-336.
59. Popovich, E.R., Wisniewski, H.M. & Barcikowska, M. (1990). Alzheimer neuropathology in non-Down's syndrome mentally retarded adults. Acta Neuropathologica, 80, 362-367.
60. Prasher, V.P. (1997). Psychotic features and effect of severity of learning disability on dementia in adults with Down Syndrome: Review of literature. British Journal of Developmental Disabilities, 43, 85-92.
61. Prasher, V.P. (2004). Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: Implications for the intellectual disability population. International Journal of International Psychiatry, 19, 509-515.
62. Prasher, V.P. & Chung, M.C. (1996). Causes of age-related cognitive decline in adaptive behavior of adults with Down Syndrome: Differential diagnoses of dementia. American Journal on Mental Retardation, 101, 175-183.
63. Prasher, V.P., Farooq, A. & Holder, R. (2004). The Adaptive Behaviour Dementia Questionnaire (ABDQ): Screening questionnaire for dementia in Alzheimer's disease in adults with Down Syndrome. Research in Developmental Disabilities, 25, 385-397.
64. Prasher, V.P. & Krishnan, V.H.R. (1993). Age of onset and duration of dementia in people with Down syndrome: Integration of 98 reported cases in the literature. International Journal of Geriatric Psychiatry, 8, 915-922.
65. Prasher, V., Viswanathan, J. & Holder, R. (2002). Down's syndrome, dementia and macrocytosis. Irish Journal of Psychological Medicine, 19, 115-120.
66. Reiss, S. (1987). Reiss Screen for Maladaptive Behavior. Worthington, OH: International Diagnostic Systems.
67. Richards, S.S. & Hendrie, H.C. (1999). Diagnosis, management and treatment of Alzheimer Disease. Archives of Internal Medicine, 159, 789-798.
68. Rivas-Vasquez, R.A., Carrazana, E.J., Rey, G.J., Biais, M.A. & Racher, D.A. (2000). Alzheimer's Disease: Pharmacological treatment and management. The Clinical Neuropsychologist, 14, 93-109.
69. Roberts, G.W., Gentleman, S.M., Lynch, A., Murray, L., Landen, M. & Graham, D.I. (1994). Amyloid protein deposition in the brain after severe head injury: Implications for the pathogenesis of Alzheimer disease. Journal of Neurology, Neurosurgery and Psychiatry, 57, 419-425.
70. Rowe, J. (2002). The ethics of assessment [Letter]. Clinical Psychology, 57, 4.
71. Royston, M.C., McKenzie, J.E., Gentleman, S.M., Sheng, J.G., Mann, D.M.A., Griffin, W.S.T et al. (1999). Overexpression of S100ß in Down's syndrome: Correlation with patient age and with ß-amyloid deposition. Neuropathology and Applied Neurobiology, 25, 387-393.
72. Salvatori, P., Tremblay, M., Sandys, J. & Marcaccio, D. (1998). Aging with an intellectual disability: A review of Canadian literature. Canadian Journal on Aging, 17, 249-271.
73. Saxton, J., McGonigle, K.L., Swihart, A.A. & Boller, F. (1993). The Severe Impairment Battery. London: Thames Valley Test Company.
74. Schupf, N., Pang, D., Patel, B.N., Silverman, W., Schubert, R., Lai, F. et al. (2003). Onset of dementia is associated with age at menopause in women with Down's Syndrome. Annals of Neurology, 54, 433-438.
75. Scott, H.D. & Laake, K. (2006). Statins for the prevention of Alzheimer's disease. The Cochrane Library of Systematic Reviews, Issue 1.
76. Shultz, J., Aman, M., Kelbley, T., Wallace, C., Burt, D.B., Primeaux-Hart, S. et al. (2004). Evaluation of screening tools for dementia in older adults with mental retardation. American Journal on Mental Retardation, 109, 98-110.
77. Silverman, J.M., Smith, C.J., Marin, D.B., Mohs, R.C. & Propper, C.B. (2003). Familial patterns of risk in very late-onset Alzheimer Disease. Archives of General Psychiatry, 60, 190-197.
78. Sims, J. (2002). The ethics of prospective assessment for dementia in people with Down's Syndrome. Clinical Psychology, 13, 30-33.
79. nd Ed. Bloomington, MN: Pearson Assessments.
80. Strydom, A., Hassiotis, A. & Walker, Z. (2002). Clinical use of structural magnetic resonance imaging in the diagnosis of dementia in adults with Down's syndrome. Irish Journal of Psychological Medicine, 19, 60-63.
81. Suzuki, Y., Yamamoto, S., Umegaki, H., Onishi, J., Mogi, H., Fujishiro, H. et al. (2004). Smell Identification Test as an indicator for cognitive impairment in Alzheimer's disease. International Journal of Geriatric Psychiatry, 19, 727-733.
82. Temple, V., Jozsvai, E., Konstantareas, M.M. & Hewitt, T.A. (2001). Alzheimer dementia in Down's syndrome: The relevance of cognitive ability. Journal of Intellectual Disability Research, 45, 47-55.
83. th ed.). Chicago: Riverside Publishing.
84. Tierney, E. (2002, June). Cognitive decline in people with and without Down Syndrome: Planning for the future. Paper presented at the Joint PSI/BPS Learning Disability Conference, Maynooth, Co. Kildare, Ireland.
85. Tiffin, J. & Asher, E.J. (1948). The Purdue Pegboard: Norms and studies of reliability and validity. Journal of Applied Psychology, 32, 234-47.
86. Tyrrell, J.F., Cosgrave, M.P., McCarron, M., McPherson, J., Calvert, J., Kelly, A. et al. (2001). Dementia in people with Down's syndrome. International Journal of Psychiatry, 16, 1168-1 174.
87. Tyrrell, J.F., Cosgrave, M.P., McLaughlin, M. & Lawlor, B.A. (1996). Dementia in an Irish population of Down's syndrome people. Irish Journal of Psychological Medicine, 13, 51-54.
88. Wetter, S. & Murphy, C. (1999). Individuals with Down's syndrome demonstrate abnormal olfactory event-related potentials. Clinical Neurophysiology, 110, 1563-1569.
89. Wilson, R.S., Mendes de Leon, C.F., Barnes, L., Schneider, J.A., Bienias, J.L., Evans, D.A. et al. (2002). Participation in cognitively stimulating activities and risk of incident Alzheimer Disease. JAMA, 287, 742.
90. th ed. Geneva: World Health Orgbisation
91. Zandi, P.P., Carlson, M.C., Plassman, B.L., Walsh-Bomer, K.A., Mayer, L.S., Steffens, D.C. et al. (2002). Hormone replacement therapy and incidence of Alzheimer Disease in older women. JAMA, 288, 2123-2129.
92. Zigman, W., Schupf, N., Devenny, D.A., Miezejeski, C., Ryan, R., Urv, T.K. et al. (2004). Incidence and prevalence of dementia in elderly adults with mental retardation without Down Syndrome. American Journal on Mental Retardation, 109, 126-141.
93. Zigman, W., Schupf, N., Haveman, M. & Silverman, W. (1997). The epidemiology of Alzheimer's Disease in mental retardation: Results and recommendations from an international conference. Journal of Intellectual Disability Research, 41, 76-80.
94. Zigman, W., Schupf, N., Sersen, E. & Silverman, W. (1995). Prevalence of dementia in adults with and without Down Syndrome. American Journal on Mental Retardation, 100, 403-412.
95. Zimbelman, K. & Wilson, C. (2000). Baseline evaluations of intellectually disabled clients who are at risk for dementia. Clinical Psychology Forum, 146, 26-29.
96. Zucco, G.M. & Negrin, N.S. (1994). Olfactory deficits in Down syndrome: A link with Alzheimer disease. Perceptual and Motor Skills, 78, 627-631.